Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
20 nov. 2023 09h13 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company focused on the development of novel DNA-damage...
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update
29 août 2023 08h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients...
Rakovina Therapeutics Announces Results from 2023 Annual General Meeting
28 juin 2023 22h55 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based...
Rakovina Therapeutics Inc. Announces Q1 2023 Financial Results and Provides Corporate Update
31 mai 2023 09h05 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 31, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients...
Rakovina Therapeutics Inc. Announces Closing of $1.5 Million Convertible Debenture Financing
29 mai 2023 20h57 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 29, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) is pleased to announce that it has closed its previously announced...
Rakovina Therapeutics Inc. Announces 2022 Financial Results and Convertible Debenture Financing
01 mai 2023 22h44 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on...
Rakovina Therapeutics Announces Presentation of New kt-3000 Series Data at AACR Annual Meeting
20 avr. 2023 12h47 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (the “Company”) (TSXV:RKV) today announced the presentation of new data describing the progress of the...
Rakovina Therapeutics to Present at the Emerging Growth Conference on April 19, 2023
17 avr. 2023 18h18 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 17, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”) is pleased to announce that it has been invited to present at...
Rakovina Therapeutics Inc. Announces Enhanced Liquidity and Investor Awareness Programs
30 mars 2023 09h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (the “Company”) (TSXV:RKV) today announced the engagement of Red Cloud Securities (“Red Cloud”) and...
Rakovina Therapeutics Receives Funding to Accelerate Development of Novel Cancer Therapies
22 mars 2023 09h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (“the Company”), is pleased to announce that it is receiving advisory services and up to...